Loading…

Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects

Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology, biochemistry and behavior biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406
Main Authors: Hoy, J.B, Cody, B.A, Karlix, J.L, Schmidt, C.J, Tebbett, I.R, Toffollo, S, Van Haaren, F, Wielbo, D
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 406
container_issue 3
container_start_page 401
container_title Pharmacology, biochemistry and behavior
container_volume 63
creator Hoy, J.B
Cody, B.A
Karlix, J.L
Schmidt, C.J
Tebbett, I.R
Toffollo, S
Van Haaren, F
Wielbo, D
description Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m 2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.
doi_str_mv 10.1016/S0091-3057(99)00014-3
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_17500933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305799000143</els_id><sourcerecordid>17500933</sourcerecordid><originalsourceid>FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153</originalsourceid><addsrcrecordid>eNpF0UtLxDAUBeAgio6Pn6BkIaKLatKkTeNGVHzBgIOO65AmtxppG006ov_ezDjq6m4-Dpx7ENql5JgSWp48EiJpxkghDqU8IoRQnrEVNKKVYFlBhVhFoz-ygTZjfE2I56VYRxuU8OQqMkKTyVdw1sfBPXeuB3wRfOcs4PN2gBDx2Bvf-cH5Huve4ulLYn7Qny5i3-AHPcRTfAO9hYCvmgbMELfRWqPbCDvLu4Werq-ml7fZ-P7m7vJ8nAHL2ZAVhAMVRV5DTZkQHIqaylwSrstKEsvLiuWiqDnluibCNAClLXPDaJUzZmjBttDBT-5b8O8ziIPqXDTQtroHP4sqhaf6jCW4t4SzugOr3oLrdPhSvz9IYH8JdDS6bYLujYv_rqqoLHliZz8MUqsPB0FF46A3YF1IxZX1LmWq-ThqMY6af15JqRbjKMa-ATgcfkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17500933</pqid></control><display><type>article</type><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</creator><creatorcontrib>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</creatorcontrib><description>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m 2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(99)00014-3</identifier><identifier>PMID: 10418780</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Cholinesterase Inhibitors - blood ; Cholinesterase Inhibitors - pharmacology ; DEET - pharmacology ; Drug Synergism ; Estrus - physiology ; Female ; Gender effect ; Insect Repellents - pharmacology ; Insecticides - pharmacology ; Locomotion ; Male ; Medical sciences ; Motor Activity - drug effects ; Muscle ; Open field ; Orientation - drug effects ; Permethrin ; Pharmacology. Drug treatments ; Physical Stimulation ; Pyrethrins - pharmacology ; Pyridostigmine bromide ; Pyridostigmine Bromide - blood ; Pyridostigmine Bromide - pharmacology ; Rats ; Rats, Sprague-Dawley ; Sex Characteristics ; Thigmotaxis</subject><ispartof>Pharmacology, biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406</ispartof><rights>1999 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1881964$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10418780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoy, J.B</creatorcontrib><creatorcontrib>Cody, B.A</creatorcontrib><creatorcontrib>Karlix, J.L</creatorcontrib><creatorcontrib>Schmidt, C.J</creatorcontrib><creatorcontrib>Tebbett, I.R</creatorcontrib><creatorcontrib>Toffollo, S</creatorcontrib><creatorcontrib>Van Haaren, F</creatorcontrib><creatorcontrib>Wielbo, D</creatorcontrib><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m 2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cholinesterase Inhibitors - blood</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>DEET - pharmacology</subject><subject>Drug Synergism</subject><subject>Estrus - physiology</subject><subject>Female</subject><subject>Gender effect</subject><subject>Insect Repellents - pharmacology</subject><subject>Insecticides - pharmacology</subject><subject>Locomotion</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Motor Activity - drug effects</subject><subject>Muscle</subject><subject>Open field</subject><subject>Orientation - drug effects</subject><subject>Permethrin</subject><subject>Pharmacology. Drug treatments</subject><subject>Physical Stimulation</subject><subject>Pyrethrins - pharmacology</subject><subject>Pyridostigmine bromide</subject><subject>Pyridostigmine Bromide - blood</subject><subject>Pyridostigmine Bromide - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sex Characteristics</subject><subject>Thigmotaxis</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpF0UtLxDAUBeAgio6Pn6BkIaKLatKkTeNGVHzBgIOO65AmtxppG006ov_ezDjq6m4-Dpx7ENql5JgSWp48EiJpxkghDqU8IoRQnrEVNKKVYFlBhVhFoz-ygTZjfE2I56VYRxuU8OQqMkKTyVdw1sfBPXeuB3wRfOcs4PN2gBDx2Bvf-cH5Huve4ulLYn7Qny5i3-AHPcRTfAO9hYCvmgbMELfRWqPbCDvLu4Werq-ml7fZ-P7m7vJ8nAHL2ZAVhAMVRV5DTZkQHIqaylwSrstKEsvLiuWiqDnluibCNAClLXPDaJUzZmjBttDBT-5b8O8ziIPqXDTQtroHP4sqhaf6jCW4t4SzugOr3oLrdPhSvz9IYH8JdDS6bYLujYv_rqqoLHliZz8MUqsPB0FF46A3YF1IxZX1LmWq-ThqMY6af15JqRbjKMa-ATgcfkw</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Hoy, J.B</creator><creator>Cody, B.A</creator><creator>Karlix, J.L</creator><creator>Schmidt, C.J</creator><creator>Tebbett, I.R</creator><creator>Toffollo, S</creator><creator>Van Haaren, F</creator><creator>Wielbo, D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope></search><sort><creationdate>19990701</creationdate><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><author>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cholinesterase Inhibitors - blood</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>DEET - pharmacology</topic><topic>Drug Synergism</topic><topic>Estrus - physiology</topic><topic>Female</topic><topic>Gender effect</topic><topic>Insect Repellents - pharmacology</topic><topic>Insecticides - pharmacology</topic><topic>Locomotion</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Motor Activity - drug effects</topic><topic>Muscle</topic><topic>Open field</topic><topic>Orientation - drug effects</topic><topic>Permethrin</topic><topic>Pharmacology. Drug treatments</topic><topic>Physical Stimulation</topic><topic>Pyrethrins - pharmacology</topic><topic>Pyridostigmine bromide</topic><topic>Pyridostigmine Bromide - blood</topic><topic>Pyridostigmine Bromide - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sex Characteristics</topic><topic>Thigmotaxis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoy, J.B</creatorcontrib><creatorcontrib>Cody, B.A</creatorcontrib><creatorcontrib>Karlix, J.L</creatorcontrib><creatorcontrib>Schmidt, C.J</creatorcontrib><creatorcontrib>Tebbett, I.R</creatorcontrib><creatorcontrib>Toffollo, S</creatorcontrib><creatorcontrib>Van Haaren, F</creatorcontrib><creatorcontrib>Wielbo, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoy, J.B</au><au>Cody, B.A</au><au>Karlix, J.L</au><au>Schmidt, C.J</au><au>Tebbett, I.R</au><au>Toffollo, S</au><au>Van Haaren, F</au><au>Wielbo, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>63</volume><issue>3</issue><spage>401</spage><epage>406</epage><pages>401-406</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m 2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10418780</pmid><doi>10.1016/S0091-3057(99)00014-3</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_17500933
source ScienceDirect Freedom Collection 2022-2024
subjects Animals
Biological and medical sciences
Cholinesterase Inhibitors - blood
Cholinesterase Inhibitors - pharmacology
DEET - pharmacology
Drug Synergism
Estrus - physiology
Female
Gender effect
Insect Repellents - pharmacology
Insecticides - pharmacology
Locomotion
Male
Medical sciences
Motor Activity - drug effects
Muscle
Open field
Orientation - drug effects
Permethrin
Pharmacology. Drug treatments
Physical Stimulation
Pyrethrins - pharmacology
Pyridostigmine bromide
Pyridostigmine Bromide - blood
Pyridostigmine Bromide - pharmacology
Rats
Rats, Sprague-Dawley
Sex Characteristics
Thigmotaxis
title Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A21%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pyridostigmine%20Bromide%20Alters%20Locomotion%20and%20Thigmotaxis%20of%20Rats:%20Gender%20Effects&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Hoy,%20J.B&rft.date=1999-07-01&rft.volume=63&rft.issue=3&rft.spage=401&rft.epage=406&rft.pages=401-406&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(99)00014-3&rft_dat=%3Cproquest_pubme%3E17500933%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17500933&rft_id=info:pmid/10418780&rfr_iscdi=true